Skip to content

Zenith Alpha G35353Recalls & reported problems

William Cook Europe ApS · Zenith Alpha, Thoracic Endovascular Graft, Proximal Component · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10827002353531), received between Jun 7, 2024 and Jun 7, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “Off-Label Use” (1 report).

2 other recalls cover devices cleared under the same FDA submission (P140016); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Off-Label Use1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 7, 2024Off-Label Use; Off-Label Use

    DESCRIPTION OF EVENT ACCORDING TO INITIAL REPORTER: THE ATTACHED DEVICE WAS USED IN A CASE TODAY. HAD PATIENT CONTACT. WAS ABLE TO REMOVED IT SUCCESSFULLY AND NO HARM CAUSED TO PATIENT. THE DOCTOR WAS SPINNING THE BLUE HANDLE AND THE TRIGGER WIRES WERE DISASSOCIATED WITH THE DEVICE. WE HAD TO BREAK BACK HANDLE AND MANUALLY RELEASE THE TRIGGER WIRES. ADDITIONAL INFORMATION RECEIVED 07FEB2024: WAS THE GRAFT ALTERED IN ANY WAY PRIOR TO IMPLANT? YES ADDITIONAL INFORMATION RECEIVED 07FEB2024: IT IS NOTED THAT ¿THE DOCTOR WAS SPINNING THE BLUE HANDLE AND THE TRIGGER WIRES WERE DISASSOCIATED WITH THE DEVICE¿. DOES THIS MEAN THAT IT WAS NOT POSSIBLE TO ROTATE THE HANDLE TO STOP AND THEREFORE KEPT TURNING? CORRECT IN THE PHYSICIAN¿S OPINION, WERE THE TRIGGER WIRES DISASSOCIATED PRIOR TO SPINNING THE BLUE HANDLE OR DID IT OCCUR DURING THE ROTATION? BEFORE WAS RELEASE TROUBLESHOOTING UTILIZED AS PER THE IFU? YES WAS THE PHYSICIAN ABLE TO LAND THE DEVICE IN THE PLANNED TARGET ZONE? YES PATIENT OUTCOME: THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS DUE TO THIS OCCURRENCE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19482794 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P140016. One submission often covers many models, so check the product and lot details in each record.

  • Z-0043-2026 · Sep 18, 2025 · Open, Classified
    Zenith Alpha 2 Thoracic Endovascular Graft, Catalog Prefix ZTA2- Reference Part Numbers ZTA2-P-40-117-W ZTA2-P-40-167 ZTA2-P-40-167-W ZTA2-P-40-217-W ZTA2-P-42-121 ZTA2-P-42-121-W
  • Z-2099-2017 · Mar 22, 2017 · Terminated
    Zenith Alpha Thoracic Endovascular Graft The Zenith Alpha" Thoracic Endovascular Graft is indicated for the endovascular treatment of patients with isolated lesions of the descend

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page